Tasly Pharmaceutical Group Co.,Ltd. Posted 686.8 Million Yuan Net Profit in First Half of 2023

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net profit of 686.8 million yuan in the first half of 2023, reversing a net loss of 472.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 4.4 billion yuan in revenue, up 8.9% year-on-year.

At the end of the reporting period, it had 17.2 billion yuan in total assets and 4.7 billion yuan in total liabilities, with a liability-to-asset ratio of 27.2%.